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Abstract 
Cancer metastasis is a complex process by which cells in a primary tumor acquire 
an aggressive phenotype, and travel to distant, secondary sites in the body.  One aspect of 
cancer metastasis is cell migration toward the vascular system, called invasion.  Multiple 
modalities of single cell invasion exist, including amoeboid migration and mesenchymal 
migration.  Amoeboid migration is less well understood, and in particular, the forces 
involved in amoeboid migration have yet to be fully elucidated at a subcellular scale.  
Cellular traction force microscopy, or CTFM, is one method used to probe migration 
forces.  However, this approach is largely limited to two dimensions, and is limited by the 
size of the pillars on the substrate.  To address these limitations, we developed a system 
using microfluidics and DNA origami capable of real-time force measurement of cell 
migration on a subcellular scale with a 10 pN resolution.   
Microfluidic devices were made using soft lithography and replica molding in our 
laboratory.  DNA origami were made using protocols developed by Michael Hudoba and 
Dr. Carlos Castro in the Nanoengineering and Biodesign Laboratory. The devices were 
imaged using TIRF microscopy to study dwell times of the sensors in the open and closed 
states, and the devices were analyzed with an AFM to determine that they are best suited 
for measuring shear forces.  Further, the presence of streptavidin protein was found to have 
a significant effect on DOFS binding with a p-value less than 0.05.  DOFS concentrations 
around 1 nM were found to provide the most coverage while minimizing structure 
 iv 
aggregation.  Thus, our microfluidic devices are able to be functionalized with DNA 
origami force sensors with a high degree of attachment.  This platform is thus capable of 
measuring cell migration and adhesion forces, and future work should harness this system 
to create 3D maps of cell migration to gain insight into invasion. 
 
 v 
Dedication 
To my uncle and childhood friend, William Moore. 
 
 vi 
Acknowledgments 
I would like to thank my research mentor, Dr. Jonathan Song, for his years of 
guidance and support throughout my undergraduate education.  In addition to research, I 
have learned so much from you, and for this I cannot thank you enough.  I have truly 
enjoyed seeing our lab grow since I was a first-year student, and I look forward to reading 
about all the great work you accomplish in the future. 
I would also like to thank my co-mentor, Dr. Carlos Castro and his former student, 
Dr. Michael Hudoba, for their assistance while working with the NanoDyn.  Through my 
research, I have started to gain an understanding of the vast potential of DNA origami, and 
I look forward to seeing all that you accomplish with this technology.  I would also like to 
thank Dr. Castro for serving as a member of the Eminence Faculty Network.  This is a great 
program for Eminence Fellows, and we all greatly appreciate your mentorship. 
To my parents, Susan Weber, William Enders, Gene Weber, and Marcy Enders, I 
am grateful for your many years of guidance.  I am who I am because of all of you, someone 
who is driven to be successful and make a difference in the world.   
This work was supported through funding from the Institute for Materials Research, 
the Second-Year Transformational Experience Program, and the College of Engineering 
Honors Research Committee at The Ohio State University. 
 
Thank you all, it has truly been an honor. 
 vii 
Vita 
Education 
2014-18 B.S. Biomedical Engineering, Summa Cum Laude 
 The Ohio State University 
 
Research and Work Experience 
2017 Biomedical Engineering Summer Intern, Laboratory of Molecular Biophysics 
 National Institutes of Health, Biochemistry and Biophysics Center 
 
2015-18 Student Researcher, Microsystems for Mechanobiology and Medicine 
Laboratory 
 The Ohio State University 
 
2015-18  Undergraduate Teaching Assistant, Fundamentals of Engineering for Honors 
Program 
 The Ohio State University 
 
Honors and Awards 
2017-18 Honors Research Scholarship, College of Engineering 
 The Ohio State University 
 
2016-18 Kettering Scholarship, Department of Biomedical Engineering 
 The Ohio State University 
 
2014-18 Eminence Fellows Scholarship 
 The Ohio State University 
 
 
Fields of Study 
Major Field: Biomedical Engineering
 viii 
Table of Contents 
 
Abstract .............................................................................................................................. iii 
Dedication ........................................................................................................................... v 
Acknowledgments.............................................................................................................. vi 
Vita .................................................................................................................................... vii 
Table of Contents ............................................................................................................. viii 
List of Figures .................................................................................................................... ix 
Chapter 1. Introduction ....................................................................................................... 1 
1.1 Cancer Metastasis ..................................................................................................... 1 
1.2 DNA Origami............................................................................................................ 3 
1.3 Microfluidics ............................................................................................................. 4 
1.4 Rationale ................................................................................................................... 5 
Chapter 2. Methods ............................................................................................................. 7 
2.1 DNA Origami Force Sensors .................................................................................... 7 
2.2 Microfluidic Devices ................................................................................................ 9 
2.3 Experimental Technique ......................................................................................... 12 
2.4 Imaging ................................................................................................................... 13 
Chapter 3. Results and Discussion .................................................................................... 15 
Chapter 4. Conclusions ..................................................................................................... 22 
4.1 Experimental Summary .......................................................................................... 22 
4.2 Problems Encountered and Future Work ................................................................ 23 
4.3 Contributions........................................................................................................... 26 
Bibliography ..................................................................................................................... 27 
Appendix A.  DOFS Counting MATLAB Code .............................................................. 29 
Appendix B. Supplemental AFM Images ......................................................................... 31 
Appendix C. Solution Preparation .................................................................................... 32 
 ix 
List of Figures 
Figure 1: Cancer cell migration phenotypes. ..................................................................... 2 
Figure 2: Double helical structure of DNA. ....................................................................... 3 
Figure 3: DOFS design process. ........................................................................................ 8 
Figure 4: NanoDyn structure showing barrels and FRET linker. ...................................... 8 
Figure 5: Jablonski diagram showing donor and acceptor energy transfer. ...................... 9 
Figure 6: Photolithography mask. .................................................................................... 10 
Figure 7: Soft lithography of PDMS................................................................................ 11 
Figure 8: Microfluidic device schematic. ........................................................................ 12 
Figure 9: Streptavidin on glass. Scale bar 10 µm. ........................................................... 15 
Figure 10: Effect of streptavidin on DOFS binding. ....................................................... 16 
Figure 11: DOFS counts at three different concentrations. ............................................. 17 
Figure 12: Example FRET image. Scale bar 10 µm. ....................................................... 18 
Figure 13: DOFS in individual microchannel.................................................................. 19 
Figure 14: FRET pair activity. ......................................................................................... 19 
Figure 15: Unbound and bound DOFS dwell times. ....................................................... 20 
Figure 16: AFM image. One DOFS shown in red box. ................................................... 21 
Figure 17: FRET image showing DOFS aggregation in microfluidic device. ................ 24 
Figure 18: DOFS uptake by non-fluorescent MDA-MB-231 cells. ................................ 25 
Figure 19: Zoomed in view of DOFS shown in Figure 16. ............................................. 31 
Figure 20: DOFS aggregation forming chains. ................................................................ 31 
 
 
 
 
 
 
 
 1 
Chapter 1. Introduction 
1.1 Cancer Metastasis 
Metastasis, or the spread of malignant cancer cells from a primary tumor to 
secondary sites in the body, is responsible for up to ninety percent of cancer-related deaths.1  
As such, the mechanisms behind metastasis are of significant research interest.  Cancer 
metastasis begins when cells in a tumor acquire an aggressive phenotype upon receiving 
cues from the microenvironment.  These cells may breach the basement membrane of the 
epithelium and begin migrating through the tumor ECM to reach the circulatory system, at 
which point they intravasate and gain access to nearly any organ in the body.2  The cells 
flow through the circulation and may become lodged in capillaries in distant organs, and 
can extravasate to form secondary tumors.2 
For cells to migrate and begin intravasation, they can degrade the ECM to create 
channels, or may navigate through tracks made by other cells. Multiple single-cell 
migration phenotypes have been observed at this stage, including mesenchymal and 
amoeboid migration.  These contrasting phenotypes are shown below in Figure 1.  
Mesenchymal migration, shown in panel (a), is a well-understood process involving 
pseudopod protrusion, the formation of focal contacts, proteolysis of the ECM, actomyosin 
contraction, and detachment of the trailing edge.2  Amoeboid migration, shown in panel 
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(b), differs in that amoeboid migration involves subcellular blebbing primarily due to 
actomyosin contraction.2   
High cell confinement and low focal adhesions have been shown to favor the 
amoeboid mechanism.  This limits the ability of cells to spread out and adhere to the 
substrate, which increases migration speed by narrowing and aligning traction forces. Anti-
cancer drugs that inhibit protease function have been shown to drive invasive cells toward 
another phenotype called amoeboid migration, where cells navigate via subcellular 
blebbing and can travel up to 30 times faster than possible in mesenchymal modalities by 
creating fewer focal contacts on the substrate.3 As such, the stereotypic convergence 
toward amoeboid migration shows this modality may serve as a drug-resistance 
mechanism.2,3 
Cells undergoing amoeboid migration are known to exert significant push forces 
normal to the substrate.4 Advances such as Cellular Traction Force Microscopy (CTFM), 
where cells displace fluorescent beads on in vitro planar substrates, have been useful in 
studying cell force mechanics.  However, this approach is largely limited to 2 dimensions, 
and the measured forces are often in directions parallel to the substrate.5,6   As a result, 
there is a gap in our understanding of amoeboid migration mechanisms. 
      
 
 
Figure 1: Cancer cell migration phenotypes. 
a b 
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1.2 DNA Origami 
Deoxyribonucleic acid, or DNA, is the genetic material of our cells.  The 
information stored within DNA is responsible for coding for proteins that have 
innumerable functions in the body.  DNA is well-known for its double-helical shape, first 
discovered by Watson and Crick in 1953 and further elucidated by Rosalind Franklin.7 This 
double helix consists of adenine-thymine and guanine-cytosine base pairs and a sugar-
phosphate backbone with a structure similar to that shown in Figure 2 below.  The figure 
is of B-form DNA, the most common structure for DNA featuring major and minor grooves 
and a perpendicular orientation of the base-pairs.  B-form DNA has a base-pair 
approximately every 0.34 nm, and makes one full 360° twist every 3.4 nm.   
Pioneered by Nadrian Seeman in the early 1980’s, DNA nanotechnology began 
with manipulating selective Watson and Crick base pairing to create immobile DNA 
junctions.8 Rothemund in 2006 showed it was possible to use a single-stranded DNA 
scaffold to develop self-assembling DNA origami structures 100 nm in diameter.9  Dietz 
 
Figure 2: Double helical structure of DNA. 
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and coworkers advanced this work and introduced base pair additions and deletions into 
DNA origami to introduce stresses that bent the structures.10   
Using these techniques, our associates at the Nanoengineering and Biodesign 
Laboratory, led by Dr. Carlos Castro, have exploited the mechanical stress in DNA 
nanostructure design and developed a DNA origami force sensor (DOFS) capable of 
measuring forces at 10 pN resolution.  The sensor contains two fluorescent dyes, one red 
that excites when the two DNA barrels of the structure are pushed close together, and one 
green that excites when the barrels are far apart.  Without applied force, the sensor is free 
to transition between the open and closed states, but the open state predominates.  When a 
force is applied to the end of the sensor, the barrels cannot move away from the closed state 
and red fluorescence is observed.  Tracking the open and closed states of the DOFS allows 
nanoscale force measurement.  Further description of the NanoDyn DOFS structure is 
provided by Hudoba et al.11–13 
 
1.3 Microfluidics 
Microfluidics is a form of lab-on-a-chip technology where systems containing 
microscale channels are used to manipulate microliters to picoliters of fluids.  The field 
first developed out of techniques used in molecular analysis and molecular biology.14  
Together, these fields share the goal of obtaining useful information with limited quantities 
of sample.  The microelectronics industry, through the technique of photolithography, or 
the manufacturing of semiconductors using silicon wafers, provided a way to make 
microfluidic systems efficiently.14  However, since the materials for microelectronics are 
not biocompatible, most work has focused on using polydimethylsiloxane, or PDMS, a soft 
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elastomer that is permeable to gases.  Thus, PDMS is better able to support cells for in vitro 
experiments.   
In recent years, microfluidics has evolved to a major research discipline, with 
applications in studying blood flow, cancer cell migration, and angiogenesis, among 
others.14–16  Microfluidic systems are often used because they allow for high-throughput in 
vitro studies that are less expensive and more controllable than other 2D and 3D 
platforms.16   
 
1.4 Rationale 
By combining the techniques of microfluidics and DNA origami, we have 
conducted a proof-of-concept study and developed a method to measure cellular traction 
forces in 3 dimensions.  As mentioned previously, there is a gap in our understanding of 
amoeboid migration mechanisms on a subcellular scale due to limitations with CTFM and 
other methods of studying mechanotransduction. 
A study by Legant et al. showed that it was possible to embed cells in a 3D PEG 
hydrogel and tracked the displacement of fluorescent beads to calculate traction forces.17 
Another study by Gjorevski et al. embedded cells in a 3D type I collagen network and 
mapped traction forces throughout the surrounding hydrogel matrix.18  However, Zhang et 
al. comment that these studies are limited in that some cancer cells and fibroblasts may 
degrade and remodel this ECM during migration, changing the properties of the ECM and 
making accurate traction force measurement difficult.19      
The present study aims to address some of these challenges.  Techniques based on 
fluorescence resonance energy transfer (FRET) to detect subcellular mechanotransduction 
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have been shown to allow for high sensitivity and force measurement on a picoNewton 
scale.  By incorporating FRET into a DNA origami force sensor and coating microfluidic 
devices with these structures, we aimed to generate 3D “heat-maps” of cell migration in 
real time.  
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Chapter 2. Methods 
2.1 DNA Origami Force Sensors 
DNA origami force sensors (DOFS) are fabricated using techniques developed by 
our collaborators in the Nanoengineering and Biodesign Laboratory.  The design of the 
NanoDyn was performed by Michael Hudoba using the caDNAno software program.  The 
first component of the DOFS is the scaffold that serves as the backbone of the structure, 
often shown as cylinders (Figure 3A).13  Here we use M13mp18 that is 7249 bases in 
length.  The scaffold winds through the entire DNA structure but is designed to not bind to 
itself (Figure 3B).13  Instead, the scaffold binds to a large number of staple strands, each 
about 30-50 bases in length, that bind to separate regions on the scaffold (Figure 3C).13  
The staples are designed to be complimentary to the scaffold strand, thus causing the DNA 
to become double-stranded after binding (Figure 3D).  About 175 unique staples are used 
in the NanoDyn structure.   
The DNA staples are custom-ordered in stock plates, and are then combined in 
specific ratios into a working stock.  The folding is set up to make a final concentration of 
20 µM scaffold in a buffer of 1 mM EDTA, 5 mM NaCl, 5 mM Tris, and 11 mM MgCl2.  
The solution is then thermally annealed starting at 65°C and cooled to 4°C over three days.  
Upon thermal annealing, the short staples bind to the scaffold, and pull the scaffold into a 
3-dimensional shape shown below in Figure 4. 
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Of note in the structure below is the presence of single stranded linkers between the 
top and bottom barrels of the structure.  This linker contains two fluorescent dyes that are 
able to undergo Förster Resonance Energy Transfer (FRET).  As shown in the Jablonski 
diagram in Figure 5, the donor fluorophore, after excitation to the S1 state, can either emit 
fluorescence and return to the S0 state, or if the acceptor is nearby, transfer its energy to the 
 
Figure 3: DOFS design process. 
 
DOFS design process. 
 
 
Figure 4: NanoDyn structure showing barrels and FRET linker. 
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acceptor.20  The acceptor fluorophore is raised to the S1 state, and will then emit a different 
fluorescent color and return to the S0 state.
20 
In the NanoDyn, Cy3 is used as the FRET donor, and Cy5 is used as the FRET 
acceptor.  The NanoDyn is designed to bend at the single-stranded linker region at an 
applied compressive force of about 10 pN, as seen in Figure 4.  This change in 
conformation causes the donor and acceptor to be pushed near each other.  As a result, 
when the donor is excited by a 561 nm laser during DOFS compression, FRET occurs and 
Cy5 emission is observed around 640 nm. 
 
2.2 Microfluidic Devices 
Development of the microfluidic devices used in these experiments begins with the 
drafting of a sketch in SolidWorks.  The sketch is then converted to an AutoCAD drawing 
and sent to a company that produces a thin plastic mask.  The mask is clear wherever the 
 
Figure 5: Jablonski diagram showing donor and acceptor energy transfer. 
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features of the device are, and is black everywhere else.  An example mask is shown below 
in Figure 6. 
Silicon wafers are purchased and developed in a cleanroom.  The wafer is first spin-
coated with a thin film of SU-8, an epoxy-based negative photoresist.  The wafer is heated 
briefly before being placed under the plastic mask described previously.  The mask and 
SU-8 coated wafer are then exposed to ultraviolet light.  The ultraviolet light causes the 
epoxy molecules to crosslink, stiffening the polymer wherever the mask is clear.  The 
wafers are removed from the aligning machine, and excess SU-8 is washed off using 
isopropyl alcohol.  After a final heating, wafers are exposed to silane using a vacuum 
chamber in our laboratory. The silane coating prevents the following soft lithography steps 
from removing the SU-8 features on the surface.   
 
Figure 6: Photolithography mask. 
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PDMS is mixed using a 10:1 ratio of solution to curing agent.  The PDMS is placed 
in a vacuum to remove excess air bubbles before the solution is poured onto a silicon wafer.  
Excess air bubbles are again removed using a vacuum before the wafer is placed in a 65°C 
oven overnight.  The features on the silicon master create indented channels in the cured 
PDMS. This process is shown below in Figure 7.21 
PDMS devices are cut from the master using a scalpel, and holes are punched in 
the devices using 1.5 mm and 4 mm biopsy punches.  These holes made in the PDMS 
enable access for culture media and cells to be added to the microchannels for our 
experiments.  The devices are cleaned with packaging tape to remove dust and debris, and 
are then placed in a plasma chamber along with thin, clean glass slides.  A vacuum pump 
is used to lower the pressure in the chamber to 600 millitorr before the plasma coil is 
activated.  Exposure to plasma for one minute and thirty seconds causes the surfaces of the 
 
Figure 7: Soft lithography of PDMS. 
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glass and PDMS to become hydrophilic.  After the devices are removed, the exposed 
surfaces are bonded together to create enclosed chambers.  
A diagram of the microfluidic device used in our work is shown in Figure 8.  
Between the center and edge ports seen on the device as circles there are rows of 
microchannels each 20 µm wide by 250 µm long.   
2.3 Experimental Technique 
To prepare the devices for experiments, 20 µL of 100 µg/mL streptavidin is flushed 
into the middle circular port immediately after bonding.  After five minutes, the device is 
flushed with phosphate-buffered saline, or PBS, and aspirated in all ports with a pipette 
and vacuum pump.  20 µL of 10 µg/mL casein is then added to the device in the center 
port, and after five minutes, the device is flushed with PBS once again.  After aspiration, 
20 µL of DOFS structures diluted to 1 nM with FOB are injected into the middle port of 
the device.    
 
Figure 8: Microfluidic device schematic. 
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Streptavidin is a protein with a high affinity for biotin.22  The DOFS are 
functionalized with biotin at the end of each barrel after fabrication.  Thus, when the DOFS 
are flushed into the center port, the pressure gradient between the full center port and empty 
edge ports forces the structures through the device.  Streptavidin has four binding sites for 
biotin; thus, when the DOFS are added, they irreversibly bind with the streptavidin.22  This 
creates 3-dimensional channels lined with sensors that change their fluorescence when 
forces are exerted on them by migrating or adhering cells. 
The cells used in these experiments are MDA-MB-231 breast cancer cells cultured 
in DMEM with 4.5 g/L D-Glucose and L-Glutamine, and 110 mg/L Sodium Pyruvate 
supplemented with 10% FBS and 1% Penicillin/Streptomycin.  MCF10A human mammary 
epithelial cells are used as controls.  Other trials have used MIA-PaCa-2 pancreatic cancer 
cells, and SCP2 modified breast cancer cells cultured in appropriate media. 
 
2.4 Imaging 
Devices are imaged using a total internal reflection microscope (TIRF).  The glass 
slide and microfluidic device are placed on the stage of the microscope.  The microscope 
is set to shine a laser at approximately a 20° angle through the sample.  The light is 
internally reflected through the sample, creating a focal plane of about 100 nm, before the 
light returns to the detector.  The microscope is also capable of performing FRET using a 
beam splitter and dichroic mirror.   
AFM imaging is carried out in collaboration with the Micro/Nano Multiphysical 
Dynamics Lab led by Dr. Hanna Cho.  Thin glass slides are plasma oxidized before 
streptavidin and casein are applied similar to the techniques described previously.  The 
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DOFS are deposited onto glass slides and allowed to adhere for 1 hour before washing with 
FOB.  Images were captured using an Asylum Research MFP-3D-Infinity. 
 
 15 
Chapter 3. Results and Discussion 
Initial work focused on optimizing the binding of streptavidin in the microfluidic 
channels.  Serial dilutions of streptavidin were done, ranging from 200 µg/mL to 20 ng/mL.  
High concentrations of streptavidin, above 20 µg/mL, resulted in coverage such as that 
shown below in Figure 9.  Here, most of the glass substrate is covered in streptavidin with 
little extra space.   
While many trials were conducted to determine which concentrations of 
streptavidin would be best suited to allow for a 1:1 strep to DOFS binding ratio, later work 
showed that excess streptavidin, around 200 µg/mL, provided better surface coverage, and 
allowed for DOFS to bind in greater amounts. 
 
Figure 9: Streptavidin on glass. Scale bar 10 µm. 
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Experiments were also conducted to determine whether streptavidin had a 
statistically significant effect on DOFS binding.  Since DOFS can theoretically bind to 
glass without any other adhesion molecules, the experiments were conducted to see if 
DOFS binding was greatly assisted through a streptavidin intermediate.  Three devices 
each were fabricated for streptavidin only and streptavidin with DOFS.  After washing with 
FOB, the devices were imaged with the TIRF microscope, and five images were captured 
for each device.  Custom MATLAB software, shown in Appendix A, was used to 
automatically count how many sensors were present using grey level thresholding.  As 
shown below in Figure 10, the DOFS only condition had a median binding of about 4 
sensors per 100 µm2, while the streptavidin increased this by two fold to about 8 sensors 
per 100 µm2.  This was determined to be statistically significant using a Wilcoxson rank 
 
Figure 10: Effect of streptavidin on DOFS binding. 
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test for difference in medians.  This supported the use of streptavidin in further experiments 
to increase DOFS binding.   
The DOFS attachment was also optimized independently.  Three devices were 
fabricated each for 1 nM (1000 pM), 100 pM, and 10 pM DOFS. Ten images were captured 
for each concentration, and the same MATLAB code used previously was used to count 
DOFS attachment.  As seen in the graph below, 1 nM DOFS had the highest concentration 
of about 32 sensors per 100 µm2.  Higher concentrations were not tested due to limitations 
during structure preparation.  In addition, higher concentrations resulted in DOFS crowding 
that made it difficult to distinguish between individual structures.  Therefore, 1 nM DOFS 
were used in subsequent experiments.  
FRET images were acquired using the TIRF microscope and attached FRET camera 
as detailed previously.  An example FRET image is shown in Figure 12 below.  The left 
panel shows the open state of the force sensor, expressing fluorescence at a 561 nm 
 
Figure 11: DOFS counts at three different concentrations. 
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excitation, while the right panel shows the closed state of the sensor with fluorescence at a 
640 nm excitation.  Ideally, the sensor with no constraining linkers should be in the open 
state when no forces are applied, and in the closed state when tensional forces are applied. 
Figure 13 below shows DOFS in an individual microchannel.  From the image, it 
can be seen that DOFS tended to distribute fairly evenly, with moderate adherence to 
channel walls.  In line with expected behavior, most DOFS remained in the open state, seen 
in the left panel, since no cells were present.   
Additional MATLAB code was used to track the DOFS through timelapse imaging.  
In brief, the code used background subtraction followed by alignment of the donor and 
acceptor channels to match the pairs through a timelapse.  The outputs of the code were 
graphs of each FRET pair activity over time and a graph of dwell times, or how long the 
sensor stayed in the open and closed configurations.  Example images of individual FRET 
 
Figure 12: Example FRET image. Scale bar 10 µm. 
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pair activity and dwell times are shown in Figure 14 and Figure 15 below.  In Figure 14 
the top panel is raw pixel brightness and the bottom panel is normalized intensity. 
It can be seen from the Figure 14 that this pair spent most of its time in the open 
state with donor excitation.  Around frame 300, the donor photobleached and no more 
signal is obtained.  Example graphs of dwell times for the Nanodyn as obtained by Dr. 
Hudoba are shown in Figure 15.11  The pink graph represents the open state of the DOFS, 
 
Figure 14: FRET pair activity. 
 
 
Figure 13: DOFS in individual microchannel. 
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while the blue graph represents the closed state.  As seen in the graphs, the force sensor 
tended to spend more time in the open state than closed state.  Similar graphs would be 
expected to be obtained in our DOFS experiments based on our obtained microchannel 
images.  
 DOFS were also imaged using atomic force microscopy in tapping mode.  Devices 
were imaged on glass with no buffer present.  An example AFM image is shown in Figure 
16 below.  As seen in the image, the DOFS tended to be horizontal on the substrate.  This 
indicates that the DOFS would be capable of measuring cell-generated shear forces rather 
than normal forces.  Other AFM images showed DOFS tended to cluster and form 
aggregates.  The DOFS tended to aggregate with the end of one device touching the end of 
another device, forming strips of DOFS that bent and connected with other strips.  An 
example image is provided in Figure 20 in Appendix B.  Future work must be done to 
explore this further.  Additional AFM images are provided in Appendix B, including a 
zoomed in view of the DOFS in Figure 16. 
 
 
Figure 15: Unbound and bound DOFS dwell times.11 
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Figure 16: AFM image. One DOFS shown in red box. 
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Chapter 4. Conclusions 
4.1 Experimental Summary 
The purpose of this work was to develop and test a system for measuring cell 
generated forces in 3-dimensional microchannels to gain a better understanding of 
amoeboid migration mechanisms in vivo.  The effect of streptavidin was first analyzed, 
followed by the concentration of the DOFS.  DOFS binding with streptavidin had a 
significantly higher concentration than DOFS on glass alone, with a p-value less than 0.05.  
Further, DOFS concentrations around 1 nM were beneficial for ensuring high coverage, 
while higher concentrations and some tests with 1 nM caused DOFS aggregation.  The 
devices were imaged using TIRF microscopy to study dwell times of the sensors in the 
open and closed states, and the devices were analyzed with an AFM to determine that they 
are best suited for measuring shear forces.  
This system provides a platform for studying cancer cell migration forces in a 
microfluidic system.  Microfluidic systems are cheap to fabricate and allow for greater 
geometric and chemical control than other in vitro systems.  Streptavidin and DOFS can 
be added to microfluidic devices efficiently and effectively, and they are capable of binding 
in 3-dimensions in confined channels. 
Recent studies have shown migrating cancer cells undergo a transition to amoeboid 
migration when confined in channels less than 10μm in width.23,24  This platform could be 
used in microfluidic channels 10 μm in height and having widths of 5 μm, 10 μm, 20 μm, 
 23 
and 50 μm that mimic mechanical confinement.  Fluorescent readouts of the DOFS may 
be compared to real-time or timelapse movies of cell migration to produce dynamic force 
maps of metastatic and normal cell migration as a function of microchannel confinement.  
This work has applications in addressing the limitations of conventional 2D and some 3D 
CTFM.  By harnessing the ability of DOFS to bind in 3 dimensions in confined 
microchannels, cells could be tracked and results could be analyzed to determine the effects 
of the amoeboid migration phenotype on cellular traction forces. 
 
4.2 Problems Encountered and Future Work 
The effects of streptavidin on DOFS binding were explored early in this research.  
Streptavidin is a tetramer, and thus is known to have four binding sites for biotin.22  
Therefore, it was expected that at least one DOFS would bind per avidin molecule.  
However, streptavidin aggregation and uneven DOFS distribution led to the ratio of DOFS 
to streptavidin molecules to be much less than one.  This did not end up affecting later 
work, since excess streptavidin should only be beneficial to increase DOFS binding. 
The DOFS were found to aggregate when added to our microfluidic devices in high 
amounts.  Images such as Figure 17 show how DOFS can completely coat the surface of 
microfluidic channels when added at concentrations near and above 1 nM.  While 
aggregation could potentially be beneficial for increasing the number of DOFS per cell for 
measuring migration forces, high sensor counts make quantification difficult.  Indeed, the 
MATLAB code used to count DOFS and measure FRET signals over time relies on 
identifying individual structures between both FRET panels.  High DOFS counts prevent 
the code from obtaining accurate measurements as individual DOFS are impossible to 
 24 
distinguish in large clusters.  It is possible that concentrations of 300-500 pM DOFS may 
be more appropriate for ensuring adequate coverage while minimizing clustering. 
Another issue was that cells imaged simultaneously with DOFS interfered with 
DOFS analysis.  Indeed, some cells appeared to internalize the DNA structures, while 
others exhibited their own fluorescence in the 561 nm range that made tracking individual 
DOFS with our MATLAB code difficult.  Even with fully non-fluorescent MDA-MD-231 
cells, the high intensity laser from the TIRF microscope caused vesicles in the cells to 
appear to fluoresce brightly, as shown below in Figure 18.  This could be alleviated through 
optimizing the FRET pair of the DOFS, as well as optimizing the focal plane for imaging 
to excite the DOFS without exciting the cells above.  
Further, as noted from the AFM experiments, DOFS appeared to be oriented 
parallel to the glass substrate.  Therefore, they would be able to measure shear forces rather 
 
Figure 17: FRET image showing DOFS aggregation in microfluidic device. 
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than normal forces.  However, amoeboid and other modes of cell migration may include 
significant forces normal to the substrate as these cells remodel and move through the 
ECM.  It is possible that contact mode or tapping mode with the AFM both result in DOFS 
being distorted to appear horizontal due to applied forces from the AFM tip.  However, 
future work should include more AFM imaging, perhaps with the addition of tunneling 
electron microscopy, to determine whether DOFS are tangential or normal to the surface 
in migration studies.  In addition, additional AFM images should be captured on mica using 
agarose gel-purified DOFS. 
Lastly, to further elucidate the coverage of DOFS in 3 dimensions, microfluidic 
systems should be imaged using confocal microscopy.  Z-stack images should be captured 
of the microfluidic device, including the glass substrate and 20 µm square channels.  The 
DOFS appear to coat the walls based on acquired TIRF images, yet confocal imaging 
 
Figure 18: DOFS uptake by non-fluorescent MDA-MB-231 cells. 
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would allow this to be verified and allow for further optimization of the DOFS coating 
protocol.   
As an additional application of this research, the system we have developed could 
be used as a drug-screening platform.  Cancer cells could be tracked using our 3D force 
mapping techniques with DOFS, and representative heat-maps as a function of mechanical 
confinement could be generated.  Then, different drugs such as taxol that interfere with 
microtubule polymerization could be applied to these cancer cells, and the resulting 
response could be measured.  For instance, cells may show reduced migration due to taxol, 
and the platform developed in this research would provide a way to obtain subcellular, 
quantitative information on how exactly the forces involved in cell migration change. 
 
4.3 Contributions 
DOFS were developed by Hudoba et al. in the Nanoengineering and Biodesign 
Laboratory led by Carlos Castro, PhD.  I designed the microfluidic devices used in these 
experiments and developed the protocol for binding the DOFS with streptavidin in the 
microfluidic chambers.  Guidance for this project was provided by Jonathan Song, PhD, 
Carlos Castro, PhD, Michael Hudoba, PhD, Ayush Garg, and Ehsan Akbari.  AFM imaging 
was conducted with Jinha Kwon in the Micro/Nano Multiphysical Dynamics Lab led by 
Hanna Cho, PhD. 
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Appendix A.  DOFS Counting MATLAB Code 
%**************************************************** 
%* DOFS_Counting.m                                  * 
%* Jacob Enders, Ayush Garg                         * 
%* Microsystems for Mechanobiology and Medicine Lab * 
%**************************************************** 
  
%% Load Image, Split Channels 
img = imread('testimage.png'); % Read image 
figure(1), imshow(img) % Show original 
  
%% Selecting Custom ROI in an Image 
roi = imrect(); 
pos = wait(roi); 
% pos = [64 64 384 384]; 
cropImg = imcrop(img, pos); 
%cropImg = img; 
%figure, imshow(cropImg), title('User Defined ROI') 
  
% Background Subtraction 
background = imopen(cropImg, strel('disk', 100)); 
i3 = rgb2gray(cropImg-background); 
  
% Contrast Enhancement 
i4 = i3; 
%i4 = imadjust(i3); 
figure(2), imshow(i4) 
 
%% Background Filtering and Region Labeling 
%level = graythresh(i4) (can use auto thresholding) 
level = 0.4; 
Ibw = im2bw(i4,level); 
  
%Additional processing 
Ibw = imfill(Ibw,'holes'); 
figure(3), imshow(Ibw), hold on 
Ibw = bwareaopen(Ibw,4); 
figure(4), imshow(Ibw), hold on 
Ibw = bwmorph(Ibw,'spur'); 
figure(5), imshow(Ibw), hold on 
label = logical(Ibw); 
  
stat = regionprops(label, 'centroid','area') 
N_initial = length(stat) 
  
%% Calculations in pixels 
% Do this in pixels 
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[m,n] = size(i4) % Find the dimensions of the selected area 
  
area_list_pixels = cell2mat({stat(:).Area}'); % Isolate Area list from 
stat struct 
  
pixels_per_dofs = 3; % CHANGE THIS TO MODIFY SIZE OF 1 DOFS 
  
% Divide all clusters by 4 pixels squared to get number of dofs in each 
cluster 
% Take the floor of each point to get a conservative estimate 
% Add up to get total dofs count in area 
N_countfinal_pixels = sum(floor(area_list_pixels/pixels_per_dofs)) 
  
% Divide number of clusters by area of image in pixels to get DOFS per 
pixel squared 
N_perpixel2 = N_countfinal_pixels/(m*n) 
  
%% Calculations in microns     
% Do this in microns 
m_um = (10/57)*m; % 57 pixels per 10 microns means .17544 um per pixel 
n_um = (10/57)*n; 
  
area_list_um = cell2mat({stat(:).Area}'); % Isolate Area list from stat 
struct 
area_list_um = area_list_um.*((10/57)^2); 
  
um_per_dofs = pixels_per_dofs*((10/57)^2); 
  
% Divide all clusters by 4 pixels squared to get number of dofs in each 
cluster 
% Take the floor of each point to get a conservative estimate 
% Add up to get total dofs count in area 
N_countfinal_um = sum(area_list_um/um_per_dofs) 
  
% Divide number of clusters by area of image in pixels to get DOFS per 
pixel squared 
N_perum2 = N_countfinal_um/(m_um*n_um) 
N_perum100um2 = floor(N_perum2*100) % Number of sensors per 100 um 
squared 
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Appendix B. Supplemental AFM Images 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Zoomed in view of DOFS shown in Figure 16. 
 
Figure 20: DOFS aggregation forming chains. 
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Appendix C. Solution Preparation 
Preparation of Streptavidin: 
1. Strep 488, volume is 10 uL, concentration 2 mg/mL  
2. Serial dilutions, add 190 uL sterile PBS and mix thoroughly to get 100 uL at 0.1 
mg/mL. Can store this for later use. 
3. Take 10 uL of the 0.1 mg/mL solution and add to 0.2mL Eppendorf tube, add 90 
uL PBS to get 100 ug/mL 
 
Preparation of PEG 8000, 500 mM NaCl 
1. Obtain 15 g of PEG, add 100 mL double distilled H2O 
2. Add 12.5 mL of 4 M NaCl solution 
3. Mix thoroughly. 
 
Preparation of 1x FOB, 11 mM MgCl2 
1. Obtain 5 mL of 10x FOB stock solution 
2. Dilute with 45 mL of double distilled H2O, total volume is 50 mL 
3. Add 400 uL of 1.375 M MgCl2 stock solution 
 
Preparation of DOFS: 
1. DOFS tube is 50 uL, add 50 uL PEG 8000, 500 mM NaCl and mix well 
2. Take 100 uL mixture and transfer to 1.5 mL Eppendorf tube 
3. Centrifuge at 16000 g, (16000 rcf) for 25 minutes, keeping track of the side of the 
tube facing up 
4. Remove from centrifuge and carefully remove all liquid, keeping the DOFS area 
away from the pipet tip. 
5. Add 50 uL of 1x FOB, 11 mM MgCl2 to get 10 nM concentration of DOFS 
6. Add 450 uL more FOB to get 1 nM concentration, standard working 
concentration 
7. Add 5 uL of 0.1% v/v Tween-20 detergent to 500 uL DOFS and mix thoroughly 
 
